32-76% Reduction in cns leukemia with a pharmacokinetically-derived intrathecal methotrexate (IT MTX) dosage regimen and a lower cranial radiation dose

A. Bleyer, P. Coccia, H. Sather

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)C-520
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
Publication statusPublished - Jan 1 1982

ASJC Scopus subject areas

  • Medicine(all)

Cite this